Originally published at news.abbvie.com. AbbVie ranked No. 15 on The Fair360, formerly DiversityInc Top 50 Companies for Diversity list in 2021.
AbbVie announced that the AbbVie Cystic Fibrosis (CF) Scholarship program is now accepting applications for the 2022-2023 academic school year. This year’s program marks 30 years of honoring and supporting young adults with CF as they pursue their educational dreams. Eligible undergraduate and graduate students are invited to apply for the scholarship until May 25, 2022, at 11:00 a.m. U.S. Eastern Time by visiting www.AbbVieCFScholarship.com. Students can apply online or by downloading an application on the official scholarship website.
“The AbbVie CF Scholarship has changed my life by providing the means to pursue my academic goals,” said Melissa W., 2021 Thriving Graduate Student. “I was honored to be recognized and have the chance to share my story with other students living with CF. A lot of people might not think they deserve recognition, but I’m proof to never underestimate yourself and reach for your dreams — great things can follow!”
AbbVie will award 40 students living with CF a $3,000 scholarship for use toward higher-education expenses during the 2022-2023 academic school year. Those 40 students will also be given the opportunity to compete for an additional $22,000 through one of two AbbVie CF Scholarship award categories: Thriving Undergraduate Student and Thriving Graduate Student.
The 2022 Thriving Undergraduate and Thriving Graduate Scholarship recipients will be announced by AbbVie in the fall. Both awards are granted based on a combination of exceptional academics and achievements, essays and creative presentations, as well as public votes.
“It has been a remarkable 30 years of celebrating the creativity, brilliance and determination of students living with CF. Year after year, we are inspired by their stories and ambition to leave a lasting impact on their communities while following pursuit of their dreams,” said John Duffey, Vice President, U.S. Specialty, AbbVie. “We are committed to upholding this legacy with the same strength and passion shown to us every year by our CF Scholars.”
The AbbVie CF Scholarship is part of the company’s ongoing commitment to the CF community, which is comprised of more than 30,000 people in the United States. Today, more than half of the CF population are age 18 or older. For more information about the scholarship, please visit www.AbbVieCFScholarship.com.
